DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

HeartRhythm

JULY 21, 2024

The global health challenge posed by cardiac arrhythmias, particularly atrial fibrillation (AF), is significant, with heightened risks of stroke, heart failure, and systemic embolism1.

Technology 45

Technology Arrhythmia Atrial Fibrillation Heart Failure 45

DAIC

JULY 16, 2024

mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. AFib is the most common type of irregular heart rhythm or arrhythmia.

AFIB 105

AFIB Technology Heart Rhythm Arrhythmia 105

HeartRhythm

AUGUST 31, 2024

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Smart technologies such as smartphones and smartwatches used in everyday life offer promising avenues for enhancing AF management.

Atrial Fibrillation 40

Atrial Fibrillation Technology Heart Rhythm Arrhythmia 40

Cardiomatics

APRIL 5, 2024

In a world where technology reigns supreme, one of the most profound tools in medicine remains the irreplaceable electrocardiogram (ECG). As technology advances, so too does our ability to capture the heart’s rhythm with greater precision. AFIB/AFL – atrial fibrillation or atrial flutter episodes.

Arrhythmia 92

Arrhythmia Tachycardia Bradycardia Electrocardiogram 92

DAIC

FEBRUARY 12, 2024

milla1cf Mon, 02/12/2024 - 15:18 February 12, 2024 — BIOTRONIK , a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward. For more information: [link] References: Thomas G, Choi DY, Doppalapudi H, et al. January CT, et al.

Technology 64

Technology Atrial Fibrillation Defibrillator Sudden Cardiac Death 64

MIBHS

JANUARY 31, 2025

In the age of technology, wearable devices have revolutionized how we approach health and wellness. This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9 million in Europe by 2060.

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

Frontiers in Cardiovascular Medicine

DECEMBER 19, 2023

Background The rising adoption of wearable technology increases the potential to identify arrhythmias. Herein, we report results of a follow-up screening protocol for incident atrial fibrillation/flutter (AF) within a large observational digital health study. Mean age was 50.5 (SD years, and 46 (53.3%) were female.

Blood Pressure 64

Blood Pressure Atrial Fibrillation AFIB Arrhythmia 64

HeartRhythm

SEPTEMBER 23, 2024

Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Rhythm Electrophysiology 40

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3 In: AF Symposium.;

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

HeartRhythm

AUGUST 31, 2024

Patients with CLL are at increased risk of developing atrial fibrillation (AF), however AF is a known side effect of ibrutinib therapy as well and is associated with worse outcomes. The incidence of atrial fibrillation (AF) is 10-15% with a median time to occurrence of 5-13 months.

Cardio Oncology 40

Cardio Oncology Technology Atrial Fibrillation Arrhythmia 40

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) catheter ablation trials report arrhythmia-free survival using different post-ablation rhythm monitoring protocols, resulting in difficulties in the interpretation of the recurrence rates and comparison of ablation strategies and technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Arrhythmia 40

Journal of Cardiovascular Electrophysiology

MARCH 19, 2025

ABSTRACT Introduction Pulmonary vein isolation (PVI) using a cryoballoon is well-established for the treatment of paroxysmal atrial fibrillation (PAF). Compared to other available technologies, the usage of a stable, low-pressure cryoballoon (POLARx, Boston Scientific) has demonstrated lower nadir temperatures and longer thawing times.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Pulmonary Technology 40

DAIC

JUNE 11, 2024

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

Journal of Cardiovascular Electrophysiology

OCTOBER 3, 2024

Abstract Introduction Atrial fibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. Despite ethical considerations and disparities, the potential benefits outweigh the challenges.

Atrial Fibrillation 40

Atrial Fibrillation AFIB Technology Heart Failure 40

HeartRhythm

APRIL 30, 2024

TARLess is a novel technology that enables LAT mapping in absence of any TAR offers promising step toward atrial fibrillation activation mapping.

Arrhythmia 40

Arrhythmia Atrial Fibrillation Technology 40

MIBHS

FEBRUARY 28, 2025

Arrhythmias: Genetic mutations can also predispose individuals to irregular heart rhythms, such as atrial fibrillation or long QT syndrome, which may increase the risk of stroke or sudden cardiac arrest. Cardiomyopathies: These diseases affect the heart muscle, impairing its ability to pump blood effectively.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52

DAIC

MARCH 26, 2024

The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Food and Drug Administration (FDA) in July 2023, a new leadless pacemaker system placed in both chambers of the heart and using a novel communication technology is now offering a more minimally invasive option for patients.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

DAIC

JULY 10, 2024

Atrial fibrillation (AFib) cases have also surged, doubling from 28.3 This includes artificial intelligence (AI), remote monitoring, virtual care, and other emerging technological advancements. Clinical empowerment: In the clinic, technology abounds but is not a panacea. And these technologies are already available.

Technology 106

Technology Best Practices AFIB Patient Care 106

DAIC

JULY 30, 2024

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

Heart BMJ

FEBRUARY 12, 2024

The National Institute for Health and Care Excellence (NICE) guidelines present a synopsis of extensive internal evidence and technology reviews, with a particular focus on clinical efficacy and cost-effectiveness within the NHS in England.

Arrhythmia 40

Arrhythmia Sudden Cardiac Death Atrial Fibrillation Heart Rhythm 40

DAIC

MAY 24, 2024

Researchers hypothesized that an AI program trained to analyze echocardiograms might help clinicians detect early, subtle changes in the hearts of patients with undiagnosed arrhythmias. “We Atrial fibrillation can come and go, so it might not be present at a doctor’s appointment. An estimated 12.1

Heart Rhythm 52

Heart Rhythm Atrial Fibrillation Echocardiogram Arrhythmia 52

HeartRhythm

AUGUST 31, 2024

Wearable technologies are being used by patients for ECG rate and rhythm monitoring. To date, it has not been possible to incorporate the collected data into clinical practice.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Technology 40

HeartRhythm

APRIL 30, 2024

Introduction: Pulsed Field Ablation (PFA) technologies are being studied in a number of clinical trials, many with strict inclusion/exclusion criteria-typically younger patients with less comorbidities undergoing de-novo PVI procedures.

Ablation 40

Ablation Atrial Fibrillation Arrhythmia Technology 40

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). ii] ClinicalTrials.gov.

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

Journal of Cardiovascular Electrophysiology

MARCH 4, 2024

ECG data during the clinical arrhythmia (ventricular tachycardia [VT], upper left figure) is analyzed with an artificial intelligence algorithm which identifies a probable location of the source of the arrhythmia (left ventricular anterolateral papillary muscle, lower left figure). cm, LVEF 50 ± 18%) and was similar to 28 controls.

Arrhythmia 40

Arrhythmia Ablation Tachycardia Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

JANUARY 10, 2024

Abstract Introduction Despite advanced ablation strategies and major technological improvements, treatment of persistent atrial fibrillation (AF) remains challenging and the underlying pathophysiology is not fully understood. Most arrhythmia recurrences were reentrant AT. After a total of 1.46 ± 0.68

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outpatient Arrhythmia 40

HeartRhythm

MAY 15, 2024

In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1 1 Catheter ablation for atrial fibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4

Electrophysiology 40

Electrophysiology Atrial Fibrillation Ablation Arrhythmia 40

DAIC

JUNE 19, 2024

By 1909 ECGs were being used to diagnose cases of arrhythmia; by 1910 to diagnose indicators of a heart attack. By the 1960s, advances in technology and medical research led to the emergence of automated ECG interpretation (AEI), based on physician-developed rules of classification.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

Dr. S. Venkatesan MD

MAY 15, 2024

RAFT AF (Again equivocal) With emerging new technologies, scientists are trying whether more safer methods like cryoablation or pulse-filed ablation would beat the rate control with drugs. Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials.”

Ablation 52

Ablation Atrial Fibrillation Technology Cardiovascular Disease 52

DAIC

MAY 17, 2024

milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the Heart Rhythm Annual Meeting in Boston (May 16-19).

Heart Rhythm 52

Heart Rhythm Technology Arrhythmia Outcomes 52

CineECG

MAY 22, 2023

Over the past 3 days cardiologists from all over the world met in New Orleans to learn and discuss the developments in technology and patient care. As ECG Excellence we are proud our CineECG technology was part of this innovation festival. Their study focuses on the issue of localizing the origin of atrial ectopic activity.

Technology 52

Technology Atrial Fibrillation Anatomy Innovation 52

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Background The newly introduced nonthermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and good safety features. Compared to PFA VHPSD-PVI might ensure information on left atrial substrate allowing to target concomitant secondary tachycardias.

Ablation 40

Ablation Pulmonary Arrhythmia Atrial Fibrillation 40

Wellnest

DECEMBER 21, 2022

Technological advancements have revolutionized the medical industry; now, portable ECG devices are also available. Atrial Fibrillation Atrial fibrillation causes irregular heartbeat, and the heart's normal blood supply is affected. Arrhythmia In simple words, arrhythmia refers to an irregular heartbeat.

Cardiac Arrest 52

Cardiac Arrest Heart attacks Heart Attack Atrial Fibrillation 52